M. L. Denney

发表

Diamino benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors. 5. Potency, efficacy, and pharmacokinetic properties of modified C-3 side chain derivatives.

R. W. Harper, N. Chirgadze, M. J. Fisher, 2000, Journal of medicinal chemistry.

Dibasic benzo[b]thiophene derivatives as a novel class of active site-directed thrombin inhibitors. 1. Determination of the serine protease selectivity, structure-activity relationships, and binding orientation.

R. W. Harper, N. Chirgadze, S. Briggs, 1997, Journal of medicinal chemistry.

Use of conformationally restricted benzamidines as arginine surrogates in the design of platelet GPIIb-IIIa receptor antagonists.

J. Wikel, J. Morin, J. Mccowan, 1997, Journal of medicinal chemistry.

A convenient synthesis of the thieno[3,2‐c]pyridine nucleus

J. Wikel, R. Vasileff, M. L. Denney, 1993 .

Characterization of LY806303 as a potent and selective inhibitor of thrombin

D. R. Berry, T. Craft, D. Gifford-Moore, 1992 .

Platelet glycoprotein IIb–IIIa receptor (GPIIb–IIIa) antagonists derived from amidinoindoles

D. R. Berry, J. Mccowan, J. A. Jakubowski, 1996 .

Dibasic benzo[B]thiophene derivatives as a novel class of active site directed thrombin inhibitors: 4. SAR studies on the conformationally restricted C3-side chain of hydroxybenzo[B]thiophenes.

K. Takeuchi, J. Mccowan, D. Gifford-Moore, 1999, Bioorganic & medicinal chemistry letters.

Diamino benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors: 3. Enhancing activity by imposing conformational restriction in the C-4" side chain.

J. Wikel, N. Chirgadze, D. Gifford-Moore, 1999, Bioorganic & medicinal chemistry letters.

Dibasic benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors: 2. Sidechain optimization and demonstration of in vivo efficacy.

R. W. Harper, A. Smith, N. Chirgadze, 1999, Bioorganic & medicinal chemistry letters.